Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Monte Rosa Therapeutics, Inc. (GLUE) had Operating Cash Flow per Share of $0.57 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$75.62M |
|
$-72.70M |
|
-- |
|
$75.62M |
|
$156.73M |
|
$-81.11M |
|
$10.98M |
|
$-70.13M |
|
$-70.13M |
|
$-72.70M |
|
$-72.70M |
|
$-72.70M |
|
$-72.70M |
|
$-81.11M |
|
$-72.99M |
|
73.91M |
|
73.91M |
|
$-0.98 |
|
$-0.98 |
|
| Balance Sheet Financials | |
$377.44M |
|
$29.48M |
|
$61.29M |
|
$438.73M |
|
$156.95M |
|
-- |
|
$58.85M |
|
$215.80M |
|
$222.94M |
|
$222.94M |
|
$222.94M |
|
61.51M |
|
| Cash Flow Statement Financials | |
$42.00M |
|
$-44.45M |
|
$98.89M |
|
$132.68M |
|
$229.12M |
|
$96.44M |
|
$18.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-107.26% |
|
-107.26% |
|
-96.52% |
|
-92.74% |
|
-96.14% |
|
$38.01M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
-- |
|
437.12 |
|
0.83 |
|
-32.61% |
|
-32.61% |
|
-16.57% |
|
-32.61% |
|
$3.62 |
|
$0.51 |
|
|
Operating Cash Flow per Share |
$0.57 |